Fulgent Genetics
FLGT
73 hedge funds and large institutions have $160M invested in Fulgent Genetics in 2019 Q4 according to their latest regulatory filings, with 42 funds opening new positions, 18 increasing their positions, 8 reducing their positions, and 4 closing their positions.
950% more first-time investments, than exits
New positions opened: 42 | Existing positions closed: 4
425% more capital invested
Capital invested by funds: $30.6M → $160M (+$130M)
125% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 8
109% more funds holding
Funds holding: 35 → 73 (+38)
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
43.24% more ownership
Funds ownership: 15.84% → 59.08% (+43%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$5.79M |
| 2 |
BBA
Baker Bros. Advisors
New York
|
+$5.28M |
| 3 |
CCM
Cadence Capital Management
Boston,
Massachusetts
|
+$1.94M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.76M |
| 5 |
BlackRock
New York
|
+$1.61M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$975K |
| 2 |
RJT
Raymond James Trust
St. Petersburg,
Florida
|
-$960K |
| 3 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
-$623K |
| 4 |
MA
Mutual Advisors
Omaha,
Nebraska
|
-$576K |
| 5 |
OWIM
Old West Investment Management
Los Angeles,
California
|
-$343K |
FLGT Hedge Fund Activity: Q4 2019 in Review
73 of the 5,092 institutional investors tracked by Wall St. Rank reported a position in Fulgent Genetics (FLGT) for Q4 2019, worth a combined $160M — up 425% from $30.6M a quarter earlier.
Buyers outnumbered sellers: 42 funds opened new FLGT positions and 4 closed out — a net gain of 38 holders — while 18 added to existing stakes and 8 trimmed.
The largest buyer was Driehaus Capital Management, adding an estimated $5.79M. The largest seller was Renaissance Technologies, cutting an estimated $975K.
- 73 institutional investors held Fulgent Genetics (FLGT) as of Q4 2019, up from 35 in Q3 2019.
- Funds reported $160M of Fulgent Genetics stock for Q4 2019, up 425% quarter-over-quarter.
- 42 funds opened new Fulgent Genetics positions in Q4 2019 and 4 closed out, a net change of +38 holders.
- The largest Fulgent Genetics buyer in Q4 2019 was Driehaus Capital Management, an estimated $5.79M added.
- The largest Fulgent Genetics seller in Q4 2019 was Renaissance Technologies, an estimated $975K sold.
Based on aggregated 13F filings for Q4 2019.